The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression
Abstract
Hepatocellular carcinoma (HCC) is a highly vascularized tumor with frequent intrahepatic metastasis. Active angiogenesis and metastasis are responsible for rapid recurrence and poor survival of HCC. We previously found that microRNA-29b (miR-29b) down-regulation was significantly associated with poor recurrence-free survival of HCC patients. Therefore, the role of miR-29b in tumor angiogenesis, invasion, and metastasis was further investigated in this study using in vitro capillary tube formation and transwell assays, in vivo subcutaneous and orthotopic xenograft mouse models, and Matrigel plug assay, and human HCC samples. Both gain- and loss-of-function studies showed that miR-29b dramatically suppressed the ability of HCC cells to promote capillary tube formation of endothelial cells and to invade extracellular matrix gel in vitro. Using mouse models, we revealed that tumors derived from miR-29b-expressed HCC cells displayed significant reduction in microvessel density and in intrahepatic metastatic capacity compared with those from the control group. Subsequent investigations revealed that matrix metalloproteinase-2 (MMP-2) was a direct target of miR-29b. The blocking of MMP-2 by neutralizing antibody or RNA interference phenocopied the antiangiogenesis and antiinvasion effects of miR-29b, whereas introduction of MMP-2 antagonized the function of miR-29b. We further disclosed that miR-29b exerted its antiangiogenesis function, at least partly, by suppressing MMP-2 expression in tumor cells and, in turn, impairing vascular endothelial growth factor receptor 2-signaling in endothelial cells. Consistently, in human HCC tissues and mouse xenograft tumors miR-29b level was inversely correlated with MMP-2 expression, as well as tumor angiogenesis, venous invasion, and metastasis. Conclusion: miR-29b deregulation contributes to angiogenesis, invasion, and metastasis of HCC. Restoration of miR-29b represents a promising new strategy in anti-HCC therapy. (Hepatology 2011;)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
Valastyan, S., Reinhardt, F., Benaich, N., Calogrias, D., Szász, A. M., Wang, Z. C., Brock, J. E., Richardson, A. L., & Weinberg, R. A. (2009) · Cell · doi:10.1016/j.cell.2009.03.047 · Cited by 820
RetractedMatrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Kerbel, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706596 · Cited by 1,948
Lee, Y. S., & Dutta, A. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092222 · Cited by 1,505
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Reinhardt, F., Onder, T. T., Valastyan, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2024 · Cited by 1,336
MicroRNA control of signal transduction
Inui, M., Martello, G., & Piccolo, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2868 · Cited by 1,272
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Targeting the tumour vasculature: insights from physiological angiogenesis
Chung, A. S., Lee, J., & Ferrara, N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2868 · Cited by 752
A MicroRNA Targeting Dicer for Metastasis Control
Martello, G., Rosato, A., Ferrari, F., Manfrin, A., Cordenonsi, M., Dupont, S., Enzo, E., Guzzardo, V., Rondina, M., Spruce, T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.05.017 · Cited by 667
Su, H., Yang, J.-R., Xu, T., Huang, J., Xu, L., Yuan, Y., & Zhuang, S.-M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2886 · Cited by 612
Self-citationArdi, V. C., Kupriyanova, T. A., Deryugina, E. I., & Quigley, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706438104 · Cited by 602
Fernández, M., Semela, D., Bruix, J., Colle, I., Pinzani, M., & Bosch, J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.011 · Cited by 600
Effects of Microrna-29 on Apoptosis, Tumorigenicity, and Prognosis of Hepatocellular Carcinoma
Xiong, Y., Fang, J.-H., Yun, J.-P., Yang, J., Zhang, Y., Jia, W.-H., & Zhuang, S.-M. (2010) · Hepatology · doi:10.1002/hep.23380 · Cited by 563
Self-citationAnand, S., Majeti, B. K., Acevedo, L. M., Murphy, E. A., Mukthavaram, R., Scheppke, L., Huang, M., Shields, D. J., Lindquist, J. N., Lapinski, P. E., et al. (2010) · Nature Medicine · doi:10.1038/nm.2186 · Cited by 517
TIMP-2 Mediated Inhibition of Angiogenesis
Seo, D.-W., Li, H., Guedez, L., Wingfield, P. T., Diaz, T., Salloum, R., Wei, B.-Y., & Stetler-Stevenson, W. G. (2003) · Cell · doi:10.1016/s0092-8674(03)00551-8 · Cited by 508
miR-296 Regulates Growth Factor Receptor Overexpression in Angiogenic Endothelial Cells
Würdinger, T., Tannous, B. A., Saydam, O., Skog, J., Grau, S., Soutschek, J., Weissleder, R., Breakefield, X. O., & Krichevsky, A. M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.005 · Cited by 463
Murphy, A. N., Unsworth, E. J., & Stetler‐Stevenson, W. G. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041570219 · Cited by 351
Zhao, J.-J., Lin, J., Lwin, T., Yang, H., Guo, J., Kong, W., Dessureault, S., Moscinski, L. C., Rezania, D., Dalton, W. S., et al. (2010) · Blood · doi:10.1182/blood-2009-09-243147 · Cited by 335
MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8
Fang, L., Deng, Z., Shatseva, T., Yang, J., Peng, C., Du, W. W., Yee, A. J., Ang, L. C., He, C., Shan, S. W., et al. (2011) · Oncogene · doi:10.1038/onc.2010.465 · Cited by 307
Self-citationWong, C. C., Wong, C., Tung, E. K., Au, S. L., Lee, J. M., Poon, R. T., Man, K., & Ng, I. O. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.006 · Cited by 295
Association of Vimentin overexpression and hepatocellular carcinoma metastasis
Hu, L., Lau, S. H., Tzang, C.-H., Wen, J.-M., Wang, W., Xie, D., Huang, M., Wang, Y., Wu, M.-C., Huang, J.-F., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1206483 · Cited by 230
Self-citationYao, J., Liang, L., Huang, S., Ding, J., Tan, N., Zhao, Y., Yan, M., Ge, C., Zhang, Z., Chen, T., et al. (2010) · Hepatology · doi:10.1002/hep.23443 · Cited by 222
Clinical role of MMP‐2/TIMP‐2 imbalance in hepatocellular carcinoma
Giannelli, G., Bergamini, C., Marinosci, F., Fransvea, E., Quaranta, M., Lupo, L., Schiraldi, O., & Antonaci, S. (2002) · International Journal of Cancer · doi:10.1002/ijc.1635 · Cited by 187
Metastamirs: a stepping stone towards improved cancer management
White, N. M. A., Fatoohi, E., Metias, M., Jung, K., Stephan, C., & Yousef, G. M. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.173 · Cited by 184
miR‐29b and miR‐125a regulate podoplanin and suppress invasion in glioblastoma
Cortez, M. A., Nicoloso, M. S., Shimizu, M., Rossi, S., Gopisetty, G., Molina, J. R., Carlotti, C. G., Tirapelli, D. P. D. C., Neder, L., Brassesco, M. S., et al. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20808 · Cited by 137
Diminished corneal angiogenesis in gelatinase A‐deficient mice
Kato, T., Kure, T., Chang, J.-H., Gabison, E. E., Itoh, T., Itohara, S., & Azar, D. T. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02897-6 · Cited by 134
Steele, R., Mott, J. L., & Ray, R. B. (2010) · Genes & Cancer · doi:10.1177/1947601910371978 · Cited by 130
Muniyappa, M. K., Dowling, P., Henry, M. A., Meleady, P., Doolan, P., Gammell, P., CLYNES, M. M., & Barron, N. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.09.014 · Cited by 119
Givvimani, S., Tyagi, N., Sen, U., et al. (2010) · Archives of Physiology and Biochemistry · doi:10.3109/13813451003652997 · Cited by 74
Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines
Lang, N., Liu, M., Tang, Q., et al. (2010) · 癌症:英文版 · doi:10.5732/cjc.009.10597 · Cited by 40
Mühlebach, M. D., Schaser, T., Zimmermann, M., Armeanu, S., Hanschmann, K.-M. O., Cattaneo, R., Bitzer, M., Lauer, U. M., Cichutek, K., & Buchholz, C. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4650 · Cited by 39
Ogasawara, S., Yano, H., Momosaki, S., Nishida, N., Takemoto, Y., Kojiro, S., & Kojiro, M. (2005) · Oncology Reports · doi:10.3892/or.13.6.1043 · Cited by 37
Lee, S.-J., Tsang, P. S., Diaz, T., Wei, B., & Stetler‐Stevenson, W. G. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2009.136 · Cited by 35
Cited by
Vandooren, J., Van den Steen, P. E., & Opdenakker, G. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.770819 · Cited by 766
Szabo, G., & Bala, S. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.87 · Cited by 588
Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications
Wong, C.-M., Tsang, F. H.-C., & Ng, I. O.-L. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.169 · Cited by 424
MicroRNAs in Common Human Diseases
Li, Y., & Kowdley, K. V. (2012) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2012.07.005 · Cited by 360
Momen-Heravi, F., Bala, S., Kodys, K., & Szabo, G. (2015) · Scientific Reports · doi:10.1038/srep09991 · Cited by 347
Metadata
- Authors
- Fang, J.-H., Zhou, H.-C., Zeng, C., Yang, J., Liu, Y., Huang, X., Zhang, J.-P., Guan, X.-Y., & Zhuang, S.-M.
- Venue
- Hepatology
- Published
- 2011-11
- Volume
- 54
- Issue
- 5
- Pages
- 1729-1740
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1990296937
- Cited by
- 307
- References
- 34
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.